Ark Invest

ARK Invest added positions in Shopify, Intellia Therapeutics, and GeneDX after significant stock declines, signaling Wood's conviction in long-term potential despite near-term headwinds.

Ark Invest purchases shares of Amazon-backed X-Energy following its IPO, signaling confidence in nuclear energy as AI data centers drive electricity demand surge.

OpenAI valued at $852B remains private with no IPO timeline. Retail investors can access exposure through Microsoft stake, ARK funds, or secondary markets.

Cathie Wood's Ark Invest bought shares of $HOOD, GeneDX, and $TSLA despite steep YTD declines, doubling down on growth bets amid market weakness.

Cathie Wood's Ark Invest sold shares of six major AI leaders on March 26, reallocating to CoreWeave, signaling bargain-hunting rather than AI retreat.

Cathie Wood's Ark Invest adds to CoreWeave, Oklo, and DoorDash after recent pullbacks, signaling conviction in AI infrastructure, nuclear energy, and established tech.

Cathie Wood praised SpaceX's record 119-satellite delivery on Transporter-16. The achievement supports anticipated IPO targeting $1.75T valuation and $75B raise.

Cathie Wood's ARK Invest pioneered actively managed ETFs focused on disruptive innovation, gaining prominence during the 2020 pandemic-driven technology surge and fundamentally reshaping the ETF industry.

ARK Invest bought just three stocks last week—Figma, Arcturus Therapeutics, and 10x Genomics—signaling selective conviction in growth equities amid broader market uncertainty.

Japanese payments firm PayPay debuted on Nasdaq at $19, 19% above IPO price, raising $880M with strong institutional backing and U.S. expansion plans.

ARK Invest argues modern defense should prioritize space, semiconductors, drones, and AI over traditional contractors, repositioning defense sector investing around technology rather than capex-heavy platforms.

Ark Invest added positions in Joby Aviation, GeneDx Holdings, and DraftKings. All three stocks have fallen significantly but offer growth potential, with Joby announcing White House partnership.

Ark Investment increased positions in Figma, CoreWeave, and Recursion Pharmaceuticals Friday, buying growth stocks trading below 2025 peaks based on valuation opportunities and emerging tech trends.

Ark Investment Management deployed $98.3 million across Shopify, Robinhood, and Roblox during market weakness, betting on long-term growth in e-commerce, fintech, and metaverse platforms.

Major institutional investors like ARK Invest and BlackRock are buying Roblox shares despite a 52% stock decline, signaling potential confidence in recovery prospects.

Bullish stock surges 15.5% as Ark Investment Management accumulates shares, suggesting institutional confidence despite 73% decline from highs and crypto market volatility.